Protalix BioTherapeutics (PLX) - Shares outstanding

Number of shares outstanding as of October 2026 : 79,986,325

According to Protalix BioTherapeutics 's latest financial reports and stock price the company's current number of shares outstanding is 79,986,325. At the end of 2026 the company had 79,986,325 shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.

Shares outstanding history for Protalix BioTherapeutics from 2020 to 2026

Shares Outstanding at the end of each year

Year	Shares Outstanding	Change
2026	79.98 M	0.89%
2025	79.28 M	7.79%
2024	73.54 M	1.75%
2023	72.28 M	46.03%
2022	49.49 M	8.65%
2021	45.55 M	38.62%
2020	32.86 M	121.48%
2019	14.83 M

Shares Outstanding for similar companies or competitors

Company	Shares Outstanding	differencediff.	Country
Pfizer PFE	5,699,000,000	7,024.97%	🇺🇸 USA
Neurocrine Biosciences NBIX	101,000,000	26.27%	🇺🇸 USA
Amicus Therapeutics FOLD	308,468,423	285.65%	🇺🇸 USA
Teva Pharmaceutical Industries TEVA	1,165,000,000	1,356.50%	🇮🇱 Israel

What is the market capitalization of a company?

The market capitalization sometimes referred as Marketcap, is the value of a publicly listed company.
In most cases it can be easily calculated by multiplying the share price with the amount of outstanding shares.

DISCLAIMER

CompaniesMarketCap is not associated in any way with CoinMarketCap.com
Stock prices are delayed, the delay can range from a few minutes to several hours.
Company logos are from the CompaniesLogo.com logo database and belong to their respective copyright holders. Companies Marketcap displays them for editorial purposes only.

Contact

For inquiries or if you want to report a problem write to hello@8marketcap.com

Links

- Privacy policy

- Terms and conditions

Number of shares outstanding for Protalix BioTherapeutics (PLX)

Number of shares outstanding as of October 2026 : 79,986,325